Brynovin

Active Ingredient(s): Sitagliptin Hydrochloride
FDA Approved: * January 16, 2025
Pharm Company: * AZURITY
Category: Diabetes

Sitagliptin, sold under the brand name Januvia among others, is an anti-diabetic medication used to treat type 2 diabetes.[4] In the United Kingdom it is listed as less preferred than metformin or a sulfonylurea.[5] It is taken by mouth.[4] It is also available in the fixed-dose combination medication sitagliptin/metformin (Janumet, Janumet XR).[4] Common side effects include headaches, swelling of the legs, and upper respiratory... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Brynovin 25 mg/ml Oral Solution
NDC: 24338-017
Labeler:
Azurity Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients